» Articles » PMID: 31199308

Using Temporal Features to Provide Data-Driven Clinical Early Warnings for Chronic Obstructive Pulmonary Disease and Asthma Care Management: Protocol for a Secondary Analysis

Overview
Journal JMIR Res Protoc
Publisher JMIR Publications
Specialty General Medicine
Date 2019 Jun 15
PMID 31199308
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Both chronic obstructive pulmonary disease (COPD) and asthma incur heavy health care burdens. To support tailored preventive care for these 2 diseases, predictive modeling is widely used to give warnings and to identify patients for care management. However, 3 gaps exist in current modeling methods owing to rarely factoring in temporal aspects showing trends and early health change: (1) existing models seldom use temporal features and often give late warnings, making care reactive. A health risk is often found at a relatively late stage of declining health, when the risk of a poor outcome is high and resolving the issue is difficult and costly. A typical model predicts patient outcomes in the next 12 months. This often does not warn early enough. If a patient will actually be hospitalized for COPD next week, intervening now could be too late to avoid the hospitalization. If temporal features were used, this patient could potentially be identified a few weeks earlier to institute preventive therapy; (2) existing models often miss many temporal features with high predictive power and have low accuracy. This makes care management enroll many patients not needing it and overlook over half of the patients needing it the most; (3) existing models often give no information on why a patient is at high risk nor about possible interventions to mitigate risk, causing busy care managers to spend more time reviewing charts and to miss suited interventions. Typical automatic explanation methods cannot handle longitudinal attributes and fully address these issues.

Objective: To fill these gaps so that more COPD and asthma patients will receive more appropriate and timely care, we will develop comprehensible data-driven methods to provide accurate early warnings of poor outcomes and to suggest tailored interventions, making care more proactive, efficient, and effective.

Methods: By conducting a secondary data analysis and surveys, the study will: (1) use temporal features to provide accurate early warnings of poor outcomes and assess the potential impact on prediction accuracy, risk warning timeliness, and outcomes; (2) automatically identify actionable temporal risk factors for each patient at high risk for future hospital use and assess the impact on prediction accuracy and outcomes; and (3) assess the impact of actionable information on clinicians' acceptance of early warnings and on perceived care plan quality.

Results: We are obtaining clinical and administrative datasets from 3 leading health care systems' enterprise data warehouses. We plan to start data analysis in 2020 and finish our study in 2025.

Conclusions: Techniques to be developed in this study can boost risk warning timeliness, model accuracy, and generalizability; improve patient finding for preventive care; help form tailored care plans; advance machine learning for many clinical applications; and be generalized for many other chronic diseases.

International Registered Report Identifier (irrid): PRR1-10.2196/13783.

Citing Articles

Identification of cancer-associated fibroblast subtypes and prognostic model development in breast cancer: role of the RUNX1/SDC1 axis in promoting invasion and metastasis.

Wu Y, Li N, Shang J, Jiang J, Liu X Cell Biol Toxicol. 2025; 41(1):21.

PMID: 39753834 PMC: 11698906. DOI: 10.1007/s10565-024-09950-w.


Error and Timeliness Analysis for Using Machine Learning to Predict Asthma Hospital Visits: Retrospective Cohort Study.

Zhang X, Luo G JMIR Med Inform. 2022; 10(6):e38220.

PMID: 35675129 PMC: 9218884. DOI: 10.2196/38220.


Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.

Zeng S, Arjomandi M, Luo G JMIR Med Inform. 2022; 10(2):e33043.

PMID: 35212634 PMC: 8917430. DOI: 10.2196/33043.


Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.

Zeng S, Arjomandi M, Tong Y, Liao Z, Luo G J Med Internet Res. 2022; 24(1):e28953.

PMID: 34989686 PMC: 8778560. DOI: 10.2196/28953.


Forecasting Future Asthma Hospital Encounters of Patients With Asthma in an Academic Health Care System: Predictive Model Development and Secondary Analysis Study.

Tong Y, Messinger A, Wilcox A, Mooney S, Davidson G, Suri P J Med Internet Res. 2021; 23(4):e22796.

PMID: 33861206 PMC: 8087967. DOI: 10.2196/22796.


References
1.
Luo G, Stone B, Fassl B, Maloney C, Gesteland P, Yerram S . Predicting asthma control deterioration in children. BMC Med Inform Decis Mak. 2015; 15:84. PMC: 4607145. DOI: 10.1186/s12911-015-0208-9. View

2.
Hochreiter S, Schmidhuber J . Long short-term memory. Neural Comput. 1997; 9(8):1735-80. DOI: 10.1162/neco.1997.9.8.1735. View

3.
Caloyeras J, Liu H, Exum E, Broderick M, Mattke S . Managing manifest diseases, but not health risks, saved PepsiCo money over seven years. Health Aff (Millwood). 2014; 33(1):124-31. DOI: 10.1377/hlthaff.2013.0625. View

4.
Fleming L . Asthma exacerbation prediction: recent insights. Curr Opin Allergy Clin Immunol. 2018; 18(2):117-123. DOI: 10.1097/ACI.0000000000000428. View

5.
Weir S, Aweh G, Clark R . Case selection for a Medicaid chronic care management program. Health Care Financ Rev. 2008; 30(1):61-74. PMC: 4195045. View